BioCryst Pharmaceuticals Inc (BCRX) News
Latest headlines that mention BCRX, newest first · each headline opens the original publisher
- Last price
- $7.75
- Day change
- -2.39%
- Next earnings
- 2026-11-02
BCRX headlines
latest coverageRare disease drug development is getting a boost from new funding models and a growing group of smaller biotech buyers.
ORLADEYO revenue hit $158.2M with 10% growth as pediatric launch exceeded expectations.
BCRX news alerts
Get an alert by email or push when a new headline mentions BCRX.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.